Search results
Results From The WOW.Com Content Network
The G4 virus, also known as the "G4 swine flu virus" (G4) and "G4 EA H1N1", is a swine influenza virus strain discovered in China. [68] The virus is a variant genotype 4 (G4) Eurasian avian-like (EA) H1N1 virus that mainly affects pigs, but there is some evidence of it infecting people. [68]
Monovalent type A influenza vaccines are generally indicated during the pandemic or the flu for everyone without contraindications. According to the Advisory Committee on Immunization Practices (ACIP) under the Centre for Disease Control and Prevention (CDC), people aged above 10 are recommended to take one dose of H1N1 vaccine while those who are 6 months to 9 years old should be injected ...
The H1N1 form of swine flu is one of the descendants of the strain that caused the 1918 flu pandemic. [ 71 ] [ 72 ] As well as persisting in pigs, the descendants of the 1918 virus have also circulated in humans through the 20th century, contributing to the normal seasonal epidemics of influenza. [ 72 ]
Bringing a jug of hand sanitizer with you when flying is one way to hopefully avoid getting the H1N1 virus, but what to do if you get the swine flu before boarding your flight? The Centers for ...
In the 21st century, a strain of H1N1 flu (since titled "H1N1pdm09") was antigenically very different from previous H1N1 strains, leading to a pandemic in 2009. Because of its close resemblance to some strains circulating in pigs, this became known as "swine flu". [45] Influenza A virus continues to circulate and evolve in birds and pigs.
On May 10, a 30-year-old man with underlying health problems died in Washington from H1N1, the first fatality in that state. [30] On May 17, 55-year-old Mitchell Wiener, an assistant principal at Intermediate School 238 in Hollis, Queens died from H1N1, making it the first H1N1 related fatality in the state of New York. Wiener suffered from ...
The following is a list of WHO recommended strains for the Northern Hemisphere influenza season. Starting in the 2012–2013 season, the recommendation shifted to include the composition of a quadrivalent influenza vaccine (QIV) that contains both influenza B lineages, alongside a trivalent influenza vaccine (TIV) containing one influenza B lineage.
Pandemrix is an influenza vaccine for influenza pandemics, such as the 2009 flu pandemic. The vaccine was developed by GlaxoSmithKline (GSK) [2] and patented in September 2006. [3] The vaccine was one of the H1N1 vaccines approved for use by the European Commission in September 2009, upon the recommendations of the European Medicines Agency ...